- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01003262
Evaluating an Emergency Department Observation Syncope Protocol for Older Adults
Syncope, defined as a transient loss of consciousness, accounts for over 700,000 annual U.S. emergency department visits and may herald a life-threatening condition in older adults (age≥60 years). Existing risk prediction instruments cannot reliably identify who among such older patients can safely be discharged home from an emergency department. As a result, the majority of older patients without a clear cause for syncope are hospitalized for diagnostic evaluation. However, current admission practices are characterized by low diagnostic yield, do not clearly improve outcomes, and account for over $2.4 billion in annual hospital costs. Most admitted patients are discharged within 48 hours, and approximately 50% of patients do not have an identified cause of syncope after their hospitalization.
The implementation of an expedited and standardized Emergency Department Observation Syncope Protocol (EDOSP) may safely reduce hospitalization of older patients with syncope. The investigators propose a pilot randomized trial to implement and evaluate EDOSP at two emergency departments. This study has the following exploratory Specific Aims:
- To compare admission rates and length-of-stay associated with EDOSP to standard care.
- To compare serious outcomes rates associated with EDOSP to standard care.
- To compare quality-of-life associated with EDOSP to standard care.
- To compare the incremental costs and cost-effectiveness of EDOSP to standard care.
Over a one-year period, 120 intermediate-risk older adults who present with syncope at the two study sites will be randomized to 1 of 2 arms: 1.) intervention arm: expedited and standardized EDOSP care; or 2.) control arm: routine care consisting of admission from the emergency department.
If this pilot trial suggests that EDOSP can safely reduce admissions, then the investigators will plan a larger study powered to evaluate clinical, quality-of-life, and economic outcomes. A successful EDOSP intervention would have important clinical policy implications and improve the emergency department care of older adults with syncope.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States
- University of Southern California
-
-
Massachusetts
-
Boston, Massachusetts, United States
- Brigham and Women's Hospital
-
-
Michigan
-
Royal Oaks, Michigan, United States, 48073
- William Beaumont Hospital
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age≥60 years
- A complaint of syncope or near-syncope (Syncope is defined as a sudden, transient loss of consciousness. Near-syncope is defined as a sensation of imminent loss of consciousness, without actual syncope.)
- Intermediate risk of adverse outcome (see Table)
- Patient speaks either English or Spanish as a primary language.
Exclusion Criteria:
- Syncope mimics (intoxication, weakness or dizziness with syncope/ near-syncope, hypoglycemia, and cardiac arrest)
- New or baseline cognitive impairment or dementia)
- Inability to provide follow-up information (e.g. homeless or resides outside of U.S.)
- Inability to speak Spanish or English
- Low- and high-risk patients (see Table).
Risk Stratification Guidelines:
- High Risk
- Serious condition identified in ED
- History of ventricular arrhythmia
- Cardiac Device with dysfunction
- Presentation consistent with acute coronary ischemia
Intermediate Risk
- No High Risk features
- Presentation not consistent with orthostatic or vasovagal syncope
Low Risk
- Presentation consistent with orthostatic or vasovagal syncope
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Emergency Department Observation
The EDOSP will consist of cardiac enzyme testing, 12-24 hours of cardiac monitoring, and echocardiogram testing by explicit criteria
|
The EDOSP will consist of cardiac enzyme testing, 12-24 hours of cardiac monitoring, and echocardiogram testing by explicit criteria
|
|
ACTIVE_COMPARATOR: Unstructured, inpatient evaluation
|
This is unstructured management by an inpatient medical team.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Admission Rate
Time Frame: Enrollment date
|
Enrollment date
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Quality of life
Time Frame: 30 days
|
30 days
|
|
30 day clinical outcomes
Time Frame: 30 days
|
30 days
|
|
Cost
Time Frame: 30 Days
|
30 Days
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Benjamin Sun, MD, MPP, University of California, Los Angeles
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3163864
- RC1AG035664-01 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Syncope
-
David B. De LurgioBiosense Webster, Inc.CompletedNeurocardiogenic Syncope | Vasovagal SyncopeUnited States
-
Tanvir HospitalEnrolling by invitationVasovagal Syncope (VVS)India
-
Gruppo Italiano Multidisciplinare per lo Studio...Completed
-
University of CalgaryRecruitingSyncope | Vasovagal Syncope (VVS)Canada
-
University of CalgaryRecruiting
-
Centre of Postgraduate Medical EducationTerminated
-
Dr. Bob SheldonVanderbilt UniversityActive, not recruitingVasovagal SyncopeUnited States, Canada, Poland
-
University of CalgaryCardiac Arrhythmia Network of CanadaCompleted
-
Gruppo Italiano Multidisciplinare per lo Studio...Completed
Clinical Trials on Emergency Department Observation Protocol
-
William Beaumont HospitalsFoundation for Education and Research in Neurological EmergenciesCompletedTransient Ischemic AttackUnited States
-
Erasmus Medical CenterCompletedEmergencies | CancerNetherlands
-
Superior UniversityActive, not recruitingConsciousness DisordersPakistan
-
Orange Park Medical CenterCompletedEmergencies | Satisfaction, Patient | Physician-Patient Relations | ExpectationsUnited States
-
Olivier HugliCompletedPain, Acute | Anxiety AcuteSwitzerland
-
Azienda Ospedaliero-Universitaria CareggiRecruitingAspiration Pneumonia | BronchoscopyItaly
-
Erasmus Medical CenterCompletedEmergencies | CancerNetherlands
-
Brigham and Women's HospitalCompleted
-
Queen's UniversityThe Physicians' Services Incorporated FoundationCompletedUltrasonography | Urolithiasis | HydronephrosisCanada
-
Northwestern UniversityNational Center for Complementary and Integrative Health (NCCIH); University... and other collaboratorsRecruitingLow Back PainUnited States